feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Scientists "Rejuvenate" Eggs, Boosting IVF

Scientists "Rejuvenate" Eggs, Boosting IVF

9 Jan

•

Summary

  • Protein injection nearly halves age-related defects in human eggs.
  • New method could significantly improve IVF success for older women.
  • Research aims to reduce genetic errors in embryos from older eggs.
Scientists "Rejuvenate" Eggs, Boosting IVF

Scientists have achieved a significant breakthrough by successfully "rejuvenating" human eggs, a development poised to dramatically enhance IVF success for older women. The research demonstrates that supplementing eggs with Shugoshin 1, a protein that declines with age, can reverse a defect causing genetic errors in embryos. Treated eggs showed a nearly 50% reduction in chromosomal abnormalities compared to untreated ones.

This innovative approach targets the decline in egg quality, a primary factor in IVF failure and miscarriage among older women. By restoring Shugoshin 1 levels, researchers aim to improve the number of chromosomally normal eggs available for fertilization. This could translate into higher pregnancy rates and fewer genetic disorders like Down's syndrome.

The findings, presented at the British Fertility Conference, have generated considerable excitement. If further trials confirm these results, the technique could offer a more efficient IVF pathway, potentially enabling conception within a single treatment cycle for many women. Discussions with regulators are underway for a clinical trial.

trending

RBI objections: Manappuram shares fall

trending

SSC CGL result released

trending

AIIMS INI CET Result

trending

MANUU rejects PPP infrastructure plans

trending

AP TET 2025 result

trending

Galaxy Z Fold 8 release

trending

Nifty Q3 earnings season

trending

Hang Seng Bank privatisation

trending

XAT 2026 answer key released

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Ovo Labs is researching the use of Shugoshin 1 protein injections to correct age-related defects in eggs, aiming to improve IVF outcomes.
Yes, the research suggests that by improving egg quality and reducing chromosomal errors, this protein therapy could significantly boost IVF success for women over 35.
Shugoshin 1 acts as a 'glue' for chromosome pairs during egg cell division; its decline with age leads to errors, which the protein supplement aims to correct.

Read more news on

Healthside-arrow

You may also like

Critical Lab Medium Shortage Halts IVF Services

18 hours ago • 3 reads

article image

PAU Invents Eco-Friendly Rodent Birth Control

3 Jan • 11 reads

article image

Shorter Wait, Better Embryos: IVF Timing Trick

26 Dec, 2025 • 84 reads

article image

Male Infertility Surges: 40% Cases Linked to Men

8 Dec, 2025 • 143 reads

article image

IVF Costs in India Skyrocket, Burdening Couples

5 Dec, 2025 • 70 reads

article image